Fuji Pharma Co., Ltd. (TYO:4554)
Japan flag Japan · Delayed Price · Currency is JPY
2,295.00
-39.00 (-1.67%)
Jun 19, 2026, 3:30 PM JST

Fuji Pharma Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Fuji Pharma stock has a consensus rating of "Strong Buy" and an average price target of ¥2,700. The average 1-year stock price forecast is 17.65% higher than the current stock price, while the lowest is ¥2,000 (-12.85%) and the highest is ¥3,400 (+48.15%).

Price Target: ¥2,700 (+17.65%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price¥2,000¥2,700¥2,700¥3,400
Change-12.85%+17.65%+17.65%+48.15%

Analyst Ratings

The average analyst rating for Fuji Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJul '25Aug '25Sep '25Nov '25Feb '26May '26
Strong Buy222222
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total222222

Financial Forecast

Revenue This Year
55.68B
from 51.68B
Increased by 7.74%
Revenue Next Year
61.06B
from 55.68B
Increased by 9.66%
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingSep 30, 2021Sep 30, 2022Sep 30, 2023Sep 30, 2024Sep 30, 2025Sep 30, 2026
Revenue
33.99B35.43B40.89B46.14B51.68B55.68B
Revenue Growth
0.58%4.23%15.42%12.84%12.01%7.74%
Gross Profit
14.75B14.56B16.52B17.84B20.76B23.25B
Gross Margin
43.40%41.10%40.39%38.68%40.18%41.75%
Operating Income
3.35B3.78B3.86B3.88B4.99B5.71B
Net Income
2.43B2.70B3.44B6.15B3.00B3.01B
Dividend / Share
29.0035.0037.0042.5045.5047.25
Dividend Growth
-20.69%5.71%14.86%7.06%3.85%
Free Cash Flow
1.39B-11.72B-4.26B599.13M535.50M-2.51B
No. Analysts
-----2
Financial currency is JPY.

Revenue Forecast

Revenue202620272028
High61.5B
Avg55.7B
Low49.9B

Revenue Growth

Revenue Growth202620272028
High
19.0%
Avg
7.7%
Low
-3.5%

EPS Forecast

EPS202620272028
High-
Avg-
Low-

EPS Growth

EPS Growth20272028
High-
Avg-
Low-